source
- Eli Lilly to acquire AtaiBeckley for $2.8 billion, signaling deeper bet on psychedelicsEli Lilly announced on Thursday that it will acquire psychedelic drug developer AtaiBeckley. The purchase price is set at $2.8 billion paid upfront. The sizable upfront payment highlights Lilly's…
- B. Braun pulls spinal anesthesia kits after recall of bupivacaine in dextrose injectionB. Braun Medical, Inc. has issued a recall of several spinal anesthesia convenience kits that contain Huons bupivacaine hydrochloride in dextrose injection. The recall follows a request from Huons…